Loading clinical trials...

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingPhase 3NCT06492291

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

This is an extension study to evaluate the longer-term safety and efficacy of enlicitide decanoate in adults with hypercholesterolemia who completed either study MK-0616-013 (NCT05952856), study MK-06...

Lead sponsor: Merck Sharp & Dohme LLC•52 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

NCT06451770 · Hypercholesterolemia, Hypertriglyceridemia, and more

RECRUITINGPhase 3

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

NCT07473960 · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

RECRUITINGNA

Pharmacogenomic Informed Statin Prescribing

NCT06568601 · Hypercholesterolemia

RECRUITING

Causes and Natural History of Dyslipidemias

NCT00353782 · Hypercholesterolemia, Atherosclerosis

RECRUITINGPhase 2

A Dose-exploration Study of EDP167 in HoFH

NCT07489209 · Homozygous Familial Hypercholesterolemia (HoFH)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 7, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhasePHASE3

Enrollment3,000

Start dateAug 2024

Last updatedOct 7, 2025

Condition

Hypercholesterolemia

Locations shown

Alliance for Multispecialty Research, LLC ( Site 0027)

Daphne, Alabama

G&L Research ( Site 0035)

Foley, Alabama

Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0048)

Phoenix, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 7, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions